Beware of Nocebo-Paternalism: Pitfalls of Tailored Nondisclosure.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. The Biosimilar Nocebo Effect? A Systematic Review of Double-Blinded Versus Open-Label Studies.Journal of managed care & specialty pharmacy · 2018
   Pooled it
2. Nocebo effects by providing informed consent in shared decision making? Not necessarily: a randomized pilot-trial using an open-label placebo approach.BMC medical ethics · 2020
   Trial
3. The "Are You OK?" Paradox: A Scoping Review of Nocebo and Negative Suggestion in Healthcare Communication.Dentistry journal · 2026
   Review
4. One-year results after transitioning from etanercept originator to biosimilar in a setting promoting shared decision-making in rheumatology.Rheumatology advances in practice · 2020
   Article
5. The Other Side of the Coin: Nocebo Effects and Psychotherapy.Frontiers in psychiatry · 2019
   Article

Corrections and comments

• Comment on
  When Respecting Autonomy Is Harmful: A Clinically Useful Approach to the Nocebo Effect.2017

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as